NYSEARCA:MYO - NYSE Arca - US62857J2015 - Common Stock - Currency: USD
The best Robotic Exoskeletons stocks are highly lucrative, given recent industry developments and growing product uptake.
Myomo (MYO) delivered earnings and revenue surprises of 0% and 6.29%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Robotics firms that may deserve a closer look by investors include AeroVironment, Cognex, and Myomo, all of which offer compelling products and tech.
These three high-tech micro-cap stocks have made solid business progress in 2024, warranting them to be on investors radars in 2025.
Mentions: FARO